For semaglutide, standard monitoring includes regular weight checks, blood glucose and HbA1c measurements (especially in diabetic patients), periodic lipid panels, and liver function tests
Hammoud, R
95% CI 1.05 to 1.44), with longer treatment periods associated with a greater risk [90]
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) A substudy of the phase 2 obesity trial specifically examined GLP3 s effects on liver fat in participants with metabolic dysfunction-associated steatotic liver disease[12]: Mean relative liver fat reduction of 82.4% with 12 mg dose at 24 weeks 86% of participants on 12 mg achieved normal liver fat levels (below 5%) at 24 weeks Liver fat reductions significantly correlated with improvements in insulin sensitivity, abdominal fat, and metabolic parameters Dose-dependent improvements observed across all dose groups compared to placebo These results suggest potential therapeutic applications beyond weight management, addressing hepatic complications of obesity and metabolic syndrome
Prioritize Protein Intake Target: 1.6 2.2g per kg body weight (0.7 1g per lb) Chicken, turkey, fish Eggs, Greek yogurt, cottage cheese Tofu, tempeh, lentils Protein shakes (whey or plant-based) 2
Spreading your protein intake throughout the day can enhance its effectiveness